Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.810
+0.050 (2.84%)
Dec 26, 2024, 4:00 PM EST - Market open
Edesa Biotech Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2017 |
| Revenue | - | - | - | - | - | 0.33 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -19.97% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 0.02 | Upgrade
|
| Gross Profit | - | - | - | - | - | 0.31 | Upgrade
|
| Selling, General & Admin | 4.13 | 4.13 | 4.43 | 5.04 | 5.73 | 3.38 | Upgrade
|
| Research & Development | 2.88 | 2.88 | 4.79 | 13.34 | 17.95 | 3.33 | Upgrade
|
| Operating Expenses | 7.01 | 7.01 | 9.22 | 18.37 | 23.68 | 6.71 | Upgrade
|
| Operating Income | -7.01 | -7.01 | -9.22 | -18.37 | -23.68 | -6.4 | Upgrade
|
| Interest & Investment Income | 0.15 | 0.15 | 0.29 | 0.06 | 0.01 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -6.88 | -6.88 | -8.95 | -18.33 | -23.68 | -6.36 | Upgrade
|
| Other Unusual Items | 0.71 | 0.71 | 0.58 | 0.78 | 10.34 | - | Upgrade
|
| Pretax Income | -6.17 | -6.17 | -8.37 | -17.55 | -13.34 | -6.36 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -6.17 | -6.17 | -8.37 | -17.55 | -13.34 | -6.36 | Upgrade
|
| Net Income to Common | -6.17 | -6.17 | -8.37 | -17.55 | -13.34 | -6.36 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 11.84% | 11.84% | 36.37% | 21.50% | 40.32% | 87.63% | Upgrade
|
| EPS (Basic) | -1.93 | -1.93 | -2.93 | -8.37 | -7.73 | -5.18 | Upgrade
|
| EPS (Diluted) | -1.93 | -1.93 | -2.93 | -8.37 | -7.73 | -5.18 | Upgrade
|
| Free Cash Flow | -4.89 | -4.89 | -6.64 | -12.28 | -13.67 | -4.99 | Upgrade
|
| Free Cash Flow Per Share | -1.53 | -1.53 | -2.32 | -5.86 | -7.92 | -4.06 | Upgrade
|
| Gross Margin | - | - | - | - | - | 94.65% | Upgrade
|
| Operating Margin | - | - | - | - | - | -1946.72% | Upgrade
|
| Profit Margin | - | - | - | - | - | -1935.59% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -1518.00% | Upgrade
|
| EBITDA | -6.9 | -6.9 | -9.12 | -18.26 | -23.57 | -6.35 | Upgrade
|
| D&A For EBITDA | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.06 | Upgrade
|
| EBIT | -7.01 | -7.01 | -9.22 | -18.37 | -23.68 | -6.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.